Details:

Corporate Authors:
National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:
Updated May 11, 2020

Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling SARS-CoV-2 specimens are provided below. For additional information on handling SARS-CoV-2 specimens, refer to the Laboratory Biosafety Frequently Asked Questions.


Content Notes:
General Guidance -- Routine Viral Testing -- Decentralized and Point of Care Testing -- Procedures with a High Likelihood to Generate Droplets or Aerosols -- Environmental Specimen Testing -- Virus Isolation -- Decontamination -- Laboratory Waste Management -- Specimen Packing and Shipping -- Resources.
Subject:
[+]
Clinical Laboratory Techniques
Containment Of Biohazards
Coronavirus Infections/diagnosis
COVID-19 Testing
Respiratory Tract Infections/diagnosis
Safety
Specimen Handling

Series:
Coronavirus Disease 2019 (CoVID-19)
Document Type:
Webpage
Genre:
Guideline
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:c4a63c8c899f99273e6ee71bc49c215bb5cf859481a6c59f0f896ca0ccab9fd7
File Type:

Supporting Files

• lab-biosafety-guidelines.html

  htm

More +